Premium Company Profile: CVS Caremark CorporationDatamonitorJanuary 2, 2008 43 Pages - SKU: DFMN1657224 |
| Introduction CVS Caremark's long-term strategy is to increase its presence in high-growth markets. The acquisition of 700 standalone drug stores strengthens the company's presence in the Mid West as well as Southern California regions. Further, the company has expanded its service portfolio through the acquisition of MinuteClinic, a provider of retail-based health clinics in the US. Scope Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies Highlights CVS Caremark offers prescription drugs and a range of general merchandise including over-the-counter drugs, beauty and personal care products, seasonal merchandise, greeting cards, and convenience foods. It offers pharmacy and font-end products under its own brands and that of other brands. CVS Caremark recorded revenues of $43,813.8 million in fiscal year ended December 2006, an increase of 18.4% over 2005. The company primarily operates in the US. The revenue growth is attributed to 18.2% growth in the retail pharmacy segment and 24.6% growth in the pharmacy benefit management segment. The company plans to expand its store base in areas where there are growth opportunities through relocating its existing stores and opening new stores. Reasons to Purchase Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization. |
Related Markets
Drug Stores Reports
- Top 100 Food & Drug Retailers (Global)
- Top 550 Chemists & Pharmacies (European)
- Top 500 Chemists & Pharmacies (Global)
- Leading Asia-Pacific Drugs, Health and Beauty Retailers – Company Benchmarking Analysis Report
- Leading Asia-Pacific Drugs, Health and Beauty Retailers – Company Benchmarking Analysis Report
